Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients

PURPOSE: To identify modifiable risk factors associated with prolonged clearance of methotrexate in pediatric, adolescent, and young adult (AYA) oncology patients receiving high dose methotrexate (HDMTX). DESIGN/METHOD: A single institution, retrospective chart review of patients receiving HDMTX bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosleh, Ema, Snyder, Stacy, Wu, Ningying, Willis, Daniel N., Hayashi, Robert J., Malone, Rema
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642233/
https://www.ncbi.nlm.nih.gov/pubmed/37965460
http://dx.doi.org/10.3389/fonc.2023.1280587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10642233/
https://www.ncbi.nlm.nih.gov/pubmed/37965460
http://dx.doi.org/10.3389/fonc.2023.1280587

Ejemplares similares